About BarioSurg
BarioSurg is a Healthcare company based in Irvine (United States) founded in 2009, and was acquired by EnteroMedics in May 2017. Minimally invasive devices for obesity and metabolic treatment are developed. BarioSurg has raised $5.5 million across 1 funding round from investors including EnteroMedics. The company was acqui-hired. Its focus areas include Life Sciences, Metabolic Diseases, Medical Devices and Therapies. Its competitors include Apollo Endo, USGI Medical and ReShape; 3 of its 3 listed competitors have raised funding.
Company details
BarioSurg, is a developer of minimally invasive and reversible technology for the treatment of obesity and metabolic disease, aiming to provide a long term, for bariatric surgeons. The company has developed their Gastric Vest System, wherein the procedure imitates gastric sleeve to induce a feeling of fullness after consuming small portions of food. The device is laparoscopically implanted, which wraps around the stomach and emulates the effect of conventional weight loss surgery, enables gastric volume reduction without permanently changing patient anatomy. The device is currently under clinical evaluation (the ENDURE study), as of May 2017. The system has received various international patents from the US, Canada, Israel, China, and Australia. As of May 2017, the product is not intended for use by the U.S. residents; it is not available for sale in the United States.
- Headquarters Irvine, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bariosurg.com
- Social LinkedIn X Facebook
- Acquired by EnteroMedics (May 2017)
- Total Equity Funding$5.5M (USD)
in 1 rounds
- Latest Funding Round$5.5M (USD), Series A
Jan 2014
- Investors
- Acquired byEnteroMedics
(May 2017)
Funding Insights of BarioSurg
BarioSurg has successfully raised a total of $5.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.5 million completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.5M
- Total Rounds 1
- Last Round Series A — $5.5M
- First Round $5.5M
(Jan 2014)
All 1 funding rounds of BarioSurg with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | $5.5M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in BarioSurg
BarioSurg has secured backing from 1 investor. Prominent investors backing the company include EnteroMedics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Satiety induction through vagal nerve block | 2002 | enteromedics.com | Saint Paul, United States |
Investor details for BarioSurg
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BarioSurg
3 dated milestones of BarioSurg across 8 years, from founding to its latest funding, stage changes and deals.
- Founded BarioSurg is founded.
- Funding First funding round of $5.5M.
- Exit Acquired by EnteroMedics.
Competitors of BarioSurg
BarioSurg has 3 listed competitors in our database, 3 of them funded. They include Apollo Endo, USGI Medical and ReShape.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| apolloendo.com | 2005 | Austin, United States | $80.36M | 132 | Therapeutic devices for obesity and GI disorders are developed. | |
| usgimedical.com | 2001 | San Clemente, United States | $45.95M | Incisionless operating platform for weight loss surgery | ||
| reshapeready.com | 2005 | San Clemente, United States | $90.32M | A dual intra-gastric balloon system is provided for weight loss. |
Detailed competitors of BarioSurg
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Metabolic Diseases
3 companies that operate in the same segment as BarioSurg (Metabolic Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BarioSurg
BarioSurg was founded in 2009 and raised its 1st funding round 5 years after it was founded.
BarioSurg is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
BarioSurg is a funded company, having raised a total of $5.5M across 1 funding round to date. The company's 1st funding round was a Series A of $5.5M, raised on Jan 2014.
BarioSurg, is a developer of minimally invasive and reversible technology for the treatment of obesity and metabolic disease, aiming to provide a long term, for bariatric surgeons. The company has developed their Gastric Vest System, wherein the procedure imitates gastric sleeve to induce a feeling of fullness after consuming small portions of food. The device is laparoscopically implanted, which wraps around the stomach and emulates the effect of conventional weight loss surgery, enables gastric volume reduction without permanently changing patient anatomy. The device is currently under clinical evaluation (the ENDURE study), as of May 2017. The system has received various international patents from the US, Canada, Israel, China, and Australia. As of May 2017, the product is not intended for use by the U.S. residents; it is not available for sale in the United States.
BarioSurg's top competitors include Apollo Endo, ReShape and USGI Medical.
BarioSurg has 1 investor. Key investors include EnteroMedics.
Yes. BarioSurg was acquired by EnteroMedics in May 2017.